Mytos develops a platform that automates the manufacture of human cell types for biotechnology applications.

Mytos

Mytos automates one of the last highly manual processes in biotech - growing human cells.Our products help teams in drug development and cell therapy save time while increasing the reproducibility of their data.Mytos is backed by a fleet of leading investors including YCombinator. Our team is made up of brilliant engineers from Dyson, Formlabs and Cambridge Consultants and driven scientists who have worked in top labs including at Imperial College, University of Cambridge and UCL. We're hiring now- visit our website to see open positions

BIO:MYTOS

Mytos